Amyloid beta-Peptides
This graph shows the total number of publications written about "Amyloid beta-Peptides" by people in the URMC Research Network by year, and whether "Amyloid beta-Peptides" was a major or minor topic of these publication.
Below are the most recent publications written about "Amyloid beta-Peptides" by people in Profiles.
-
Salloway S, Sperling R, Keren R, Porsteinsson AP, van Dyck CH, Tariot PN, Gilman S, Arnold D, Abushakra S, Hernandez C, Crans G, Liang E, Quinn G, Bairu M, Pastrak A, Cedarbaum JM. A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology. 2011 Sep 27; 77(13):1253-62.
-
Davtyan H, Ghochikyan A, Cadagan R, Zamarin D, Petrushina I, Movsesyan N, Martinez-Sobrido L, Albrecht RA, García-Sastre A, Agadjanyan MG. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease. J Transl Med. 2011; 9:127.
-
Schor NF. What the halted phase III ?-secretase inhibitor trial may (or may not) be telling us. Ann Neurol. 2011 Feb; 69(2):237-9.
-
Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS. Amyloid imaging of Lewy body-associated disorders. Mov Disord. 2010 Nov 15; 25(15):2516-23.
-
Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid ß-peptide elimination from the brain. J Neurochem. 2010 Dec; 115(5):1077-89.
-
Nyhlén J, Constantinescu R, Zetterberg H. Problems associated with fluid biomarkers for Parkinson's disease. Biomark Med. 2010 Oct; 4(5):671-81.
-
Dolan PJ, Johnson GV. The role of tau kinases in Alzheimer's disease. Curr Opin Drug Discov Devel. 2010 Sep; 13(5):595-603.
-
Heneka MT, O'Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm. 2010 Aug; 117(8):919-47.
-
Ryan DA, Mastrangelo MA, Narrow WC, Sullivan MA, Federoff HJ, Bowers WJ. Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease mice. Mol Ther. 2010 Aug; 18(8):1471-81.
-
Taddei K, Laws SM, Verdile G, Munns S, D'Costa K, Harvey AR, Martins IJ, Hill F, Levy E, Shaw JE, Martins RN. Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity. Neurobiol Aging. 2010 Feb; 31(2):203-14.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
